Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 78.01K 72.06K 65.3K 122K 8.29M 124K 867K 343K 4.34M 328K 321K 13.7M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 219M 203M 184M 344M 23.33B 349M 2.44B 966M 12.22B 922M 903M 38.53B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.60%+1.95%+36.91%+70.90% 400.43B
Weighted average by Cap. -0.26%+2.66%+40.99%+82.13%

Financials

2016 2017
Net sales 54.27M 48.46M 44.77M 40.57M 75.91M 5.15B 77.16M 539M 213M 2.7B 204M 199M 8.51B 106M 94.61M 87.4M 79.21M 148M 10.06B 151M 1.05B 416M 5.27B 398M 389M 16.61B
Net income -103M -91.96M -84.95M -76.99M -144M -9.78B -146M -1.02B -405M -5.12B -386M -378M -16.15B -125M -112M -103M -93.6M -175M -11.89B -178M -1.24B -492M -6.23B -470M -460M -19.63B
Net Debt 209M 187M 173M 157M 293M 19.89B 298M 2.08B 823M 10.42B 786M 770M 32.85B 246M 219M 203M 184M 344M 23.32B 349M 2.44B 965M 12.22B 922M 902M 38.52B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock